Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by CravenRaven101on Jun 01, 2011 3:17pm

285 Views

Post# 18658093

RE: RE: Importance of Squamous Trial

You realize of course JL that referring to yourself in the 3rd person is cause to worry your family and friends... IT must be killing you NOT to have crowed about the gains last week... LOL...it is nice having a quieter board... I take it the powers that be have taken to removing your aliases OR are you just trying to create an inventory of user names to feed your delusions later... and have whole arguments backed by your imaginary supporters???

In any case keep up the the posts... YOU were and are always good for a laugh

it's My opinion git yer own

Bullboard Posts

Understanding different debt management strategies (good debt vs. bad debt)